Comparing pre- and post-COVID-19 chronic allergy prevalence in children using National Health and Nutrition

Bomi Kim1, Sunyeob Choi2

  • 1Department of Nursing, Honam University, Gwangju, and.

Allergologie Select
|April 9, 2026
PubMed

Insights

The COVID-19 pandemic minimally impacted childhood asthma, atopic dermatitis, and rhinitis prevalence in South Korea. While some demographic factors like vaccination rates shifted, allergic disease rates remained stable between 2019 and 2021.

Area of Science:

  • Pediatric Allergy and Immunology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic introduced significant societal changes impacting public health.
  • Understanding its effects on children's health, particularly allergic diseases, is crucial.

Purpose of the Study:

  • To assess changes in demographic characteristics, parental smoking, and the prevalence of asthma, atopic dermatitis, and rhinitis in South Korean children.
  • To compare these factors before (2019) and after (2021) the COVID-19 pandemic.

Main Methods:

  • Retrospective analysis of national health survey data from 2019 and 2021.
  • Inclusion of children aged 3–18 years, analyzing demographic, parental, and health-related factors.
  • Statistical adjustment for general and parent-related characteristics to evaluate disease prevalence.

Main Results:

  • Influenza vaccination rates and maternal age at first birth showed significant increases between 2019 and 2021.
  • No significant difference in asthma prevalence was observed after adjusting for covariates.
  • Atopic dermatitis showed gender distribution differences in 2021, while rhinitis showed differences in age, area, and breastfeeding status.

Conclusions:

  • The COVID-19 pandemic influenced specific demographic trends but did not significantly alter the prevalence of childhood asthma, atopic dermatitis, or rhinitis.
  • Highlights the need for ongoing monitoring of social changes' impact on child health during major global events.
  • Further research is recommended to explore the long-term health consequences.
Abstract

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...